BE845099A - Derives pyrrolidiniques et leur application pharmacologique - Google Patents

Derives pyrrolidiniques et leur application pharmacologique

Info

Publication number
BE845099A
BE845099A BE6045634A BE6045634A BE845099A BE 845099 A BE845099 A BE 845099A BE 6045634 A BE6045634 A BE 6045634A BE 6045634 A BE6045634 A BE 6045634A BE 845099 A BE845099 A BE 845099A
Authority
BE
Belgium
Prior art keywords
pyrrolidin derivatives
pharmacological application
pharmacological
application
pyrrolidin
Prior art date
Application number
BE6045634A
Other languages
English (en)
French (fr)
Inventor
G Pifferi
M Pinza
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE845099A publication Critical patent/BE845099A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
BE6045634A 1975-08-13 1976-08-11 Derives pyrrolidiniques et leur application pharmacologique BE845099A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT26326/75A IT1045043B (it) 1975-08-13 1975-08-13 Derivati pirrolidinici

Publications (1)

Publication Number Publication Date
BE845099A true BE845099A (fr) 1977-02-11

Family

ID=11219233

Family Applications (1)

Application Number Title Priority Date Filing Date
BE6045634A BE845099A (fr) 1975-08-13 1976-08-11 Derives pyrrolidiniques et leur application pharmacologique

Country Status (27)

Country Link
US (1) US4118396A (da)
JP (1) JPS5822034B2 (da)
AR (1) AR212176A1 (da)
AT (1) AT353783B (da)
AU (1) AU506651B2 (da)
BE (1) BE845099A (da)
CA (1) CA1077947A (da)
CH (1) CH624935A5 (da)
CS (1) CS214766B2 (da)
DD (1) DD127966B3 (da)
DE (1) DE2635853C2 (da)
DK (1) DK156055C (da)
ES (1) ES450643A1 (da)
FI (1) FI62290C (da)
FR (1) FR2320741A1 (da)
GB (1) GB1550160A (da)
HU (1) HU173742B (da)
IN (1) IN144871B (da)
IT (1) IT1045043B (da)
MX (1) MX4717E (da)
NL (1) NL179052C (da)
NO (1) NO146909C (da)
NZ (1) NZ181726A (da)
PL (1) PL101471B1 (da)
SE (1) SE420599B (da)
SU (1) SU663302A3 (da)
YU (1) YU40147B (da)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452807A (en) * 1981-02-05 1984-06-05 Hoffmann-La Roche Inc. (R,S)-1-(3-Hydroxy-4-methoxybenzoyl)-3-hydroxy-2-pyrrolidinone intermediates therefor and use for treating cerebral insufficiency
US4461906A (en) * 1979-08-09 1984-07-24 Hoffmann-La Roche Inc. Pyrrolidine 2-one derivatives
US4476308A (en) * 1981-07-24 1984-10-09 Hoffmann-La Roche Inc. 1-Pyrrolidine acetamides

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1075280B (it) 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
IT1075564B (it) 1977-02-11 1985-04-22 Isf Spa Procedimento per la preparazione di derivati pirrolidinici
GB1580559A (en) * 1977-11-24 1980-12-03 Wyeth John & Brother Ltd Amide cerivatives
IT1141287B (it) * 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
IT1206699B (it) * 1984-02-27 1989-04-27 Isf Spa Procedimento per preparare derivati di pirrolidone.
CH666483A5 (de) * 1985-01-16 1988-07-29 Lonza Ag Verfahren zur herstellung von thiotetronsaeure.
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
EP0223328B1 (en) 1985-07-26 1992-01-29 Denki Kagaku Kogyo Kabushiki Kaisha Process for producing oxiracetam
CH668423A5 (de) * 1986-06-19 1988-12-30 Lonza Ag Verfahren zur herstellung von 4-alkoxy-3-pyrrolin-2-onen.
HU195773B (en) * 1985-09-24 1988-07-28 Lonza Ag Process for preparing alkyl esters of 4-alkoxy-3-pyrrolin-2-on-1-yl-acetic acid
IL80071A0 (en) * 1985-09-24 1986-12-31 Lonza Ag Pyrrolidine acetamide derivatives
US4677114A (en) * 1985-11-22 1987-06-30 Warner-Lambert Company Pyrrolidone-2 derivatives and pharmaceutical compositions thereof
CH668424A5 (de) * 1986-06-26 1988-12-30 Lonza Ag 4-benzyloxy-3-pyrrolin-2-on-l-yl-acetamid, dessen herstellung und verwendung.
CH668422A5 (de) * 1986-06-26 1988-12-30 Lonza Ag 4-benzyloxy-3-pyrrolin-2-on, dessen herstellung und verwendung zur synthese von tetramsaeure.
IT1224168B (it) * 1986-08-01 1990-09-26 Finanziaria R F Spa Ora Finanz Derivati del pirrolidin-2-one ad attivita' nootropa
CH667655A5 (de) * 1986-09-24 1988-10-31 Lonza Ag Verfahren zur herstellung von 4-alkoxy-2(5h)-thiophenonen.
CH670644A5 (da) * 1986-12-18 1989-06-30 Lonza Ag
US5202345A (en) * 1987-08-19 1993-04-13 Shionogi & Co., Ltd. Carbamoylpyrrolidone derivatives and drugs for senile dementia
CA1305148C (en) * 1987-08-19 1992-07-14 Hiromu Matsumura Carbamoylpyrrolidone derivatives and drugs for senile dementia
DE3813416A1 (de) * 1988-04-21 1989-11-02 Hoechst Ag 3,4-dihydroxypyrrolidin-2-on-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
JP2660201B2 (ja) * 1988-08-05 1997-10-08 塩野義製薬株式会社 新規ピロロ［１，４］ベンゾジアゼピン誘導体および老人性痴呆薬
JPH02115162A (ja) * 1988-09-06 1990-04-27 Lonza Ag ５―アルキルテトラム酸およびその製造方法
IL93051A0 (en) * 1989-01-17 1990-11-05 Hoffmann La Roche ((5-oxo-2-pyrrolidinyl)methyl)cyclohexaneacetamides,their preparation and pharmaceutical compositions containing them
FI95034C (fi) * 1989-03-15 1995-12-11 Lonza Ag Menetelmä 1,3-substituoidun tetrahydro-1H-tieno/3,4-d/-imidatsol-2(3H)-on-4-ylideenipentaanihappoesterin valmistamiseksi
CH680293A5 (da) * 1990-06-26 1992-07-31 Lonza Ag
JP3038032B2 (ja) * 1991-03-25 2000-05-08 日清製粉株式会社 血小板凝集抑制薬
WO2002053153A1 (fr) 2000-12-28 2002-07-11 Daiichi Pharmaceutical Co., Ltd. Medicaments permettant de traiter et de prevenir une douleur neurologique
EP1993998B1 (en) * 2005-12-07 2013-08-21 UCB Pharma, S.A. 3-carboxy- 2-oxo-1 -pyrrolidine derivatives and their uses
DK3260118T3 (da) * 2008-10-16 2021-04-19 Univ Johns Hopkins Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
CA2789014C (en) * 2010-02-09 2019-01-15 Michela Gallagher Methods and compositions for improving cognitive function
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
CA2904767C (en) 2013-03-15 2022-06-21 Agenebio, Inc. Methods and compositions for improving cognitive function
WO2016191288A1 (en) 2015-05-22 2016-12-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
CN105820102A (zh) * 2016-05-10 2016-08-03 武汉工程大学 奥拉西坦的合成工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011886B (de) * 1952-04-29 1957-07-11 Waldemar Kutscher Dr Ing Dr Me Verfahren zur Herstellung von Aminoalkylpyrrolen
GB1309692A (en) * 1970-02-13 1973-03-14 Ucb Sa N-substituted lactams
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
US3541111A (en) * 1968-05-08 1970-11-17 Du Pont Pyrrolinecarboxanilide compounds
US3577432A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-phenoxypyrrolidines

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461906A (en) * 1979-08-09 1984-07-24 Hoffmann-La Roche Inc. Pyrrolidine 2-one derivatives
US4452807A (en) * 1981-02-05 1984-06-05 Hoffmann-La Roche Inc. (R,S)-1-(3-Hydroxy-4-methoxybenzoyl)-3-hydroxy-2-pyrrolidinone intermediates therefor and use for treating cerebral insufficiency
US4476308A (en) * 1981-07-24 1984-10-09 Hoffmann-La Roche Inc. 1-Pyrrolidine acetamides
US4650878A (en) * 1981-07-24 1987-03-17 Hoffmann-La Roche Inc. 2-(2-oxo-1-pyrrolidinyl) acetic acids
US5034402A (en) * 1981-07-24 1991-07-23 Hoffmann-La Roche Inc. Methods and pharmaceutical compositions using pyrrolidine derivatives

Also Published As

Publication number Publication date
JPS5822034B2 (ja) 1983-05-06
AU1679776A (en) 1978-02-16
CS214766B2 (en) 1982-05-28
FI62290C (fi) 1982-12-10
NO146909B (no) 1982-09-20
SE420599B (sv) 1981-10-19
FI762314A (da) 1977-02-14
DE2635853C2 (de) 1984-05-30
DK156055B (da) 1989-06-19
SU663302A3 (ru) 1979-05-15
DE2635853A1 (de) 1977-02-24
NZ181726A (en) 1978-09-20
NO762791L (da) 1977-02-15
NL179052C (nl) 1986-07-01
NO146909C (no) 1982-12-29
ES450643A1 (es) 1977-08-01
CA1077947A (en) 1980-05-20
DK156055C (da) 1989-12-04
PL101471B1 (pl) 1978-12-30
AR212176A1 (es) 1978-05-31
US4118396A (en) 1978-10-03
IN144871B (da) 1978-07-22
SE7608938L (sv) 1977-02-14
DD127966A5 (de) 1977-10-26
FI62290B (fi) 1982-08-31
CH624935A5 (da) 1981-08-31
AU506651B2 (en) 1980-01-17
NL7608946A (nl) 1977-02-15
GB1550160A (en) 1979-08-08
ATA589476A (de) 1979-05-15
MX4717E (es) 1982-08-13
JPS5223072A (en) 1977-02-21
NL179052B (nl) 1986-02-03
YU40147B (en) 1985-08-31
FR2320741A1 (fr) 1977-03-11
DK365176A (da) 1977-02-14
HU173742B (hu) 1979-08-28
IT1045043B (it) 1980-04-21
YU196476A (en) 1982-06-30
DD127966B3 (de) 1983-03-30
AT353783B (de) 1979-12-10
FR2320741B1 (da) 1979-03-02

Similar Documents

Publication Publication Date Title
BE845099A (fr) Derives pyrrolidiniques et leur application pharmacologique
BE847196A (fr) Pyridinyl-2(1h)-pyridinones et leur preparation
FR2341576A1 (fr) 2-piperazinyl-6,7-dimethoxyquinazolines et leur application pharmacologique
FR2325653A1 (fr) Alcoxysilanes en amas et leur obtention
BE838079A (fr) Derives de tetrahydroisoquinoleine et leur procede de preparation
FR2318863A1 (fr) Bestatine et ses derives
FR2297046A1 (fr) Derives d'adamantane et leur application
SE7604829L (sv) Flistvettare
BE845100A (fr) Derives pyrroliniques et leur application pharmacologique
FR2322608A1 (fr) Aminoglycosides et leur preparation
FR2319378A1 (fr) Tripeptides et leur preparation
SE7608476L (sv) Farmakologiska foreningar
BE844029A (fr) Diepoxy-androstanes et leur preparation
BE837341A (fr) Nouveaux derives de morpholine et leur preparation
BE845612A (fr) Derives de tetrazole-5-carboxamide et leur preparation
FR2301249A1 (fr) Derives du 3-amino-4-carbamyl-pyrrole et leur preparation
BE851509A (fr) Derives de piperidine et leur preparation
FR2313358A1 (fr) Urethanne-polythiols et leur preparation
BE839035A (fr) Derives de triazolobenzocycloalkylthiadiazine, leur preparation et leur utilisation
BE843395A (fr) Sulfonamido-salicylaldehydes, leur obtention et leur application
FR2315275A1 (fr) 1-acyl-1,2,3,4-tetrahydro-6-quinoleinols et leur preparation
FR2322143A1 (fr) Epoxy-cyclohexenes et derives
BE837595A (fr) Nouveaux derives de nitroimidazole et leur preparation
FR2319683A1 (fr) Pigments azoiques et leur preparation
FR2301572A1 (fr) Pigments azoiques et leur preparation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ISF S.P.A.

Effective date: 19930831